PayerTalkCE Presents: Real-time Continuous Glucose Monitoring Impact on Glycemic Control and Acute Metabolic Events

This podcast features discussions on the impact of real-time continuous glucose monitoring (CGM) on glycemic control and acute metabolic events among insulin-treated diabetes patients. Dr. Jeffrey Dunn (Cooperative Benefits Group) and Dr. Richard Dlott (formerly The Permanente Medical Group (TPMG) / Kaiser Permanente Northern California) look at the findings of a recent study published in JAMA, which observed significant benefits of CGM in both type 1 and type 2 diabetes patients, including notable A1c reductions and decreased emergency room visits for hypoglycemia. They emphasize the importance of patient engagement in diabetes management and explore the implications of new CMS quality measures for 2023 on health plans. The conversation highlights the potential for CGM to transform diabetes care by providing real-time data that can empower patients and inform treatment decisions, underscoring the need for health plans to consider broader access to this technology.

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcarecgm.com/impactpayertalk/.